Merit Medical Systems Files 8-K Report
Ticker: MMSI · Form: 8-K · Filed: Jan 28, 2025 · CIK: 856982
| Field | Detail |
|---|---|
| Company | Merit Medical Systems Inc (MMSI) |
| Form Type | 8-K |
| Filed Date | Jan 28, 2025 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 4 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 8-k, regulation-fd
Related Tickers: MMSI
TL;DR
MERIT files standard 8-K, no major news yet.
AI Summary
On January 28, 2025, Merit Medical Systems, Inc. filed an 8-K report. The filing primarily concerns Regulation FD disclosures and the filing of financial statements and exhibits. No specific financial figures or new material events were detailed in the provided excerpt.
Why It Matters
This filing indicates Merit Medical Systems is adhering to its reporting obligations with the SEC, which is standard practice for publicly traded companies.
Risk Assessment
Risk Level: low — The filing is a routine 8-K report for disclosures and exhibits, not indicating any immediate material changes or risks.
Key Players & Entities
- MERIT MEDICAL SYSTEMS INC (company) — Registrant
- January 28, 2025 (date) — Date of Report
- 0000856982-25-000006 (other) — Accession Number
- 870447695 (other) — IRS Number
- UT (other) — State of Incorporation
- 1600 WEST MERIT PARKWAY (other) — Business Address
- SOUTH JORDAN (other) — City
- 84095 (other) — ZIP Code
- 8012531600 (other) — Business Phone
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is for Regulation FD Disclosure and to report Financial Statements and Exhibits.
What is the exact name of the registrant?
The exact name of the registrant is Merit Medical Systems, Inc.
On what date was this report filed?
The report was filed on January 28, 2025.
In which state was Merit Medical Systems, Inc. incorporated?
Merit Medical Systems, Inc. was incorporated in Utah.
What is the principal executive office address for Merit Medical Systems, Inc.?
The principal executive office address is 1600 West Merit Parkway, South Jordan, Utah 84095.
Filing Stats: 953 words · 4 min read · ~3 pages · Grade level 13.8 · Accepted 2025-01-28 16:35:48
Filing Documents
- mmsi-20250128x8k.htm (8-K) — 49KB
- mmsi-20250128xex99d1.htm (EX-99.1) — 123KB
- mmsi-20250128x8k001.jpg (GRAPHIC) — 11KB
- 0000856982-25-000006.txt ( ) — 341KB
- mmsi-20250128.xsd (EX-101.SCH) — 3KB
- mmsi-20250128_lab.xml (EX-101.LAB) — 15KB
- mmsi-20250128_pre.xml (EX-101.PRE) — 9KB
- mmsi-20250128x8k_htm.xml (XML) — 5KB
01 Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure . On January 28, 2025, Merit Medical Systems, Inc. ("Merit") is conducting a conference call to discuss commercial, marketing and industry updates related to its WRAPSODY Cell-Impermeable Endoprosthesis (the "Wrapsody CIE"). In connection with the conference call, Merit released the prepared remarks to be delivered during the conference call, a copy of which is furnished as Exhibit 99.1 to this report. The information contained in this Item 7.01 of this Current Report on Form 8-K (including the exhibit attached hereto) is furnished pursuant to General Instruction B.2. of Form 8-K and shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing made by the Company under the Securities Act of 1933, as amended, or the Exchange Act. CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS This Current Report and the exhibit hereto contain forward-looking statements about Merit that involve substantial risks and uncertainties. Merit intends such statements, and all subsequent forward-looking statements attributable to Merit, to be expressly qualified in their entirety by these cautionary statements and covered by the safe harbor provisions for forward-looking statements contained in Section 21E of the Exchange Act and Section 27A of the Securities Act. In some cases, forward-looking statements can be identified by the use of terminology such as "anticipate," "believe," "continue," "estimate," "expect," "forecast," "intend," "may," "might," "plan," "potential," "project," "will," "would," "seek," "should," "could," "can," "predict," "potential," "continue," "objective" or other forms of these words or similar words or expressions, or the negative thereof or other comparable terminology. However, not all forward-looking statements contain such ide
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits EXHIBIT NUMBER DESCRIPTION 99.1 Conference Call Remarks. 104 The cover page from this Current Report on Form 8-K, formatted in Inline XBRL
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. MERIT MEDICAL SYSTEMS, INC. Date: January 28, 2025 By: /s/ Brian G. Lloyd Brian G. Lloyd Chief Legal Officer and Corporate Secretary 3